News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
IPG Expands a Nationwide Agreement With Aetna to be Its Designated Implantable Device Benefit Management Provider
May 7, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ATLANTA--(BUSINESS WIRE)--IPG and Aetna (NYSE: AET) are pleased to announce the expansion of their Implantable Device Benefit Management (DBM) program into North Carolina and South Carolina.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Opinion
How To Bring Generic Drug Manufacturing Back to the US
September 30, 2025
·
5 min read
·
Vic Suarez
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
September 29, 2025
·
1 min read
·
Annalee Armstrong
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
September 29, 2025
·
4 min read
·
Annalee Armstrong
Layoffs
Biogen Shuffles 20 Staff After Ending AAV Work
September 29, 2025
·
2 min read
·
Tristan Manalac